Catheter Precision Makes NYSE American Section 610(b) Public Announcement

Rhea-AI Summary

Catheter Precision (NYSE: VTAK), a US medical device company specializing in cardiac electrophysiology products, has made a mandatory public announcement under NYSE American Company Guide Section 610(b). The company disclosed that its audited financial statements for the year ended December 31, 2024, included an independent audit opinion containing a Substantial Doubt Regarding Going Concern paragraph.

This disclosure, previously included in the company's Annual Report on Form 10-K filed March 31, 2025, does not represent any changes or amendments to the consolidated financial statements or the annual report.

Positive

• None.

Negative

• Auditors expressed substantial doubt about company's ability to continue as going concern
• Significant financial viability concerns indicated by the audit opinion

News Market Reaction

-6.91%

1 alert

-6.91% News Effect

On the day this news was published, VTAK declined 6.91%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Fort Mill, S.C., April 17, 2025 (GLOBE NEWSWIRE) -- -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that, as previously disclosed in its Annual Report on Form 10-K for the year ended December 31, 2024, filed March 31, 2025, with the Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included a Substantial Doubt Regarding Going Concern paragraph. See further discussion in footnote 1 to the Company's consolidated financial statements included in the Company's Annual Report on Form 10-K.

This announcement is made pursuant to NYSE American Company Guide Section 610(b), which requires separate public announcement of the receipt of an audit opinion containing a going concern paragraph. This announcement does not represent any change or amendment to the Company's consolidated financial statements or to its Annual Report on Form 10-K for the year ended December 31, 2024.

CONTACTS:

At the Company
David Jenkins
973-691-2000
info@catheterprecision.com

FAQ

What does the going concern warning mean for Catheter Precision (VTAK) investors?

A going concern warning indicates substantial doubt about the company's ability to continue operating, suggesting significant financial challenges that could affect investor holdings.

When did Catheter Precision (VTAK) receive the going concern audit opinion?

The going concern audit opinion was included in Catheter Precision's Annual Report on Form 10-K for the year ended December 31, 2024, filed March 31, 2025.

What are the NYSE American Section 610(b) requirements for Catheter Precision (VTAK)?

NYSE American Section 610(b) requires companies to make a separate public announcement when receiving an audit opinion containing a going concern paragraph.

Will the going concern announcement affect Catheter Precision's (VTAK) NYSE American listing?

While the going concern warning doesn't automatically affect listing status, it may impact compliance with NYSE American continued listing standards.